 |
(S)-3′-(OH)-desazadesferrithiocin-polyether, magnesium salt |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic iron overload requiring chelation therapy |
| EU Market Approval | EU |
| EU Designation Date | 2009-07-24 00:00:00 |
| Sponsor | Shire Pharmaceutical Development Limited |
| |
(S)-3′-(OH)-desazadesferrithiocin-polyether, magnesium salt |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic iron overload requiring chelation therapy |
| EU Market Approval | EU |
| EU Designation Date | 2009-07-24 00:00:00 |
| Sponsor | Shire Pharmaceutical Development Limited |